How to Adjust CrCl for Obese Patients

The Cockcroft-Gault equation multiplies by body weight because weight stands in for muscle mass, and muscle mass determines creatinine production. In an obese patient that substitution breaks down — adipose tissue produces very little creatinine — and using actual body weight credits the patient with clearance they do not have.

This is the largest routine source of error in CrCl calculation, and it is entirely avoidable.

How much difference does it make?

A 55-year-old man, 120 kg, 175 cm, serum creatinine 1.2 mg/dL:

IBW   = 50 + 2.3 × (68.9 − 60)          = 70.5 kg
BMI   = 120 / 1.75²                      = 39.2 kg/m²
AdjBW = 70.5 + 0.4 × (120 − 70.5)        = 90.3 kg

| Weight basis | Weight used | CrCl | | --- | --- | --- | | Actual | 120.0 kg | 118.1 mL/min | | Adjusted | 90.3 kg | 88.8 mL/min | | Ideal | 70.5 kg | 69.3 mL/min |

A 49 mL/min spread from the same patient and the same creatinine. Actual weight overestimates the conventional figure by 33%.

For a drug with a dose reduction at 90 mL/min, the weight basis alone decides whether this patient gets a reduced dose. That is not a rounding difference — it is a different prescription.

The equations

Ideal body weight — Devine (1974)

Male:   IBW (kg) = 50.0 + 2.3 × (height in inches − 60)
Female: IBW (kg) = 45.5 + 2.3 × (height in inches − 60)

Adjusted body weight

AdjBW (kg) = IBW + 0.4 × (actual weight − IBW)

The 0.4 factor reflects that adipose tissue contributes some clearance capacity — increased blood volume and some lean mass accompany weight gain — but far less than proportionally. Some references use 0.3; 0.4 is the convention for Cockcroft-Gault in renal dosing.

Which to use

| Situation | Weight basis | | --- | --- | | Actual weight below IBW | Actual | | BMI < 25 | Ideal | | BMI 25–29.9 | Ideal, or adjusted above 120% of IBW | | BMI ≥ 30, or actual > 120–130% of IBW | Adjusted | | BMI ≥ 40 | Adjusted; consider Salazar-Corcoran |

These are practice convention, not validated rules. They are widespread and defensible, but they were not derived from a trial, and institutions differ. Where your local protocol specifies something different, follow the local protocol.

Note the first row. In an underweight patient, using IBW would inflate the result. Always compare actual against ideal before deciding — the rule is not "always use IBW in normal patients", it is "use the smaller of actual and ideal, unless obesity pushes you to adjusted".

Salazar-Corcoran

An obesity-specific alternative, derived in obese subjects rather than adapted from a normal-weight equation:

Male:   CrCl = [(137 − age) × ((0.285 × wt kg) + (12.1 × ht m²))] / (51 × Scr)
Female: CrCl = [(146 − age) × ((0.287 × wt kg) + (9.74 × ht m²))] / (60 × Scr)

It uses total body weight and height separately, estimating fat-free mass internally rather than requiring you to pick a weight basis.

Do not apply it to normal-weight patients. It was developed in an obese population and is not validated outside it.

In practice, Salazar-Corcoran is best used as a cross-check. If it and Cockcroft-Gault with adjusted weight agree closely, you can be reasonably confident. If they diverge widely, that itself is information — and a reason to consider measuring rather than estimating.

Why this goes wrong so often

Three reasons, all of them systemic rather than individual:

1. Most calculators do not ask. They take a weight, apply the equation, and return a number. The user has no signal that a decision was made on their behalf — and the default is actual weight, which is the wrong answer for the patient most likely to need care taken.
2. Weight is often estimated. An estimated weight in an obese patient can be out by 10–15 kg, and that error compounds the weight-basis error.
3. The result looks plausible. 118 mL/min for a 55-year-old is not obviously wrong. Nothing about it prompts a second look.

The special populations calculator shows all three weight bases simultaneously with the conventional choice marked, alongside Salazar-Corcoran — so the decision is visible rather than silent.

Edge cases

BMI 25–30. The judgement zone. Compare actual against IBW: below about 120% of ideal, use IBW; above it, adjusted becomes more defensible. The difference in this range is usually small.

Extreme obesity (BMI > 50). Every estimating equation carries more uncertainty here, and all were derived with few such patients. If the dosing decision is high-consequence, a timed urine collection is a materially better answer than any estimate.

Obesity plus reduced muscle mass. Sarcopenic obesity — common in older patients — breaks both assumptions at once. Weight overstates muscle mass, and creatinine understates impairment. Consider cystatin C, which does not depend on muscle mass at all; the CKD-EPI cystatin C equations are on this site.

Obesity in acute kidney injury. Fix the more fundamental problem first: in AKI no creatinine-based estimate is valid, regardless of weight basis.

Summary

• Actual body weight in an obese patient overestimates clearance, often by 30% or more.
• Use adjusted body weight at BMI ≥ 30 or above 120% of ideal weight.
• Use the smaller of actual and ideal in underweight patients.
• Salazar-Corcoran is a useful cross-check, for obese patients only.
• Weigh the patient. An estimated weight compounds the error.
• These rules are convention. Institutional protocol takes precedence.

Adjacent question: does the drug itself change the answer?

The weight-basis rules above are about estimating clearance. A separate question is which weight to use for the dose itself, and the two are not the same.

For a renally cleared drug dosed per kilogram, you may legitimately use one weight to estimate clearance and a different one to calculate the mg. Which weight applies to the dose depends on how the drug distributes:

• Hydrophilic drugs (aminoglycosides, beta-lactams) distribute mainly into lean tissue, so dosing weight is usually ideal or adjusted body weight.
• Lipophilic drugs distribute into adipose tissue as well, so total body weight may be appropriate.

Using adjusted body weight for the clearance estimate and then also assuming it for the dose — without checking the label — is a common and avoidable error.

Adjacent question: bariatric surgery

Weight after bariatric surgery falls rapidly, and a clearance calculated pre-operatively is obsolete within weeks. Two practical points:

• Recalculate at each review during the weight-loss phase rather than carrying forward an old figure.
• Muscle mass falls alongside fat, so serum creatinine may drift down for reasons that have nothing to do with improved kidney function.

The full comparison, worked

55-year-old man, 120 kg, 175 cm, serum creatinine 1.2 mg/dL:

| Basis | Weight used | CrCl | Note | | --- | --- | --- | --- | | Actual | 120.0 kg | 118.1 mL/min | Overestimates — adipose produces little creatinine | | Adjusted | 90.3 kg | 88.8 mL/min | Conventional at BMI ≥ 30 | | Ideal | 70.5 kg | 69.3 mL/min | Under-credits a genuinely larger person | | Salazar-Corcoran | n/a | 95.5 mL/min | Obesity-specific cross-check |

The conventional answer and the obesity-specific equation land within about 7% of each other, which is reassuring. The actual-weight figure sits 33% above both — and it is the default in most calculators.

Run all four side by side on the special populations calculator.